Doximity, Inc. (NYSE:DOCS - Get Free Report) CAO Siddharth Sitaram sold 1,770 shares of Doximity stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $24.94, for a total value of $44,143.80. Following the completion of the transaction, the chief accounting officer directly owned 97,004 shares of the company's stock, valued at approximately $2,419,279.76. This trade represents a 1.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Siddharth Sitaram also recently made the following trade(s):
- On Monday, June 8th, Siddharth Sitaram sold 2,444 shares of Doximity stock. The shares were sold at an average price of $20.41, for a total value of $49,882.04.
Doximity Price Performance
NYSE DOCS opened at $24.60 on Tuesday. The business has a 50 day simple moving average of $21.80 and a 200 day simple moving average of $23.62. Doximity, Inc. has a one year low of $17.15 and a one year high of $76.51. The stock has a market capitalization of $4.38 billion, a P/E ratio of 28.94, a P/E/G ratio of 17.10 and a beta of 1.29.
Doximity (NYSE:DOCS - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.13. Doximity had a return on equity of 18.06% and a net margin of 25.48%.The business had revenue of $156.62 million during the quarter. During the same quarter in the previous year, the firm posted $0.36 earnings per share. The company's revenue for the quarter was up 7.3% compared to the same quarter last year. Equities analysts expect that Doximity, Inc. will post 0.84 earnings per share for the current year.
Institutional Trading of Doximity
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Public Employees Retirement System of Ohio acquired a new position in shares of Doximity during the second quarter valued at about $778,000. Handelsbanken Fonder AB boosted its stake in Doximity by 5.4% during the 2nd quarter. Handelsbanken Fonder AB now owns 39,300 shares of the company's stock valued at $815,000 after purchasing an additional 2,000 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in Doximity by 34.3% during the 2nd quarter. Central Pacific Bank Trust Division now owns 6,972 shares of the company's stock worth $145,000 after purchasing an additional 1,780 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of Doximity by 108.0% in the first quarter. Pacer Advisors Inc. now owns 908,938 shares of the company's stock worth $21,178,000 after purchasing an additional 471,972 shares during the last quarter. Finally, Empowered Funds LLC lifted its holdings in shares of Doximity by 163.5% in the first quarter. Empowered Funds LLC now owns 32,239 shares of the company's stock valued at $751,000 after purchasing an additional 20,006 shares in the last quarter. Institutional investors own 87.19% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on DOCS shares. KeyCorp lowered shares of Doximity from an "overweight" rating to a "sector weight" rating in a research note on Thursday, May 14th. Wolfe Research upgraded shares of Doximity to an "outperform" rating in a report on Thursday. Robert W. Baird reaffirmed a "neutral" rating and issued a $18.00 price target (down from $40.00) on shares of Doximity in a research note on Thursday, May 14th. Truist Financial upped their price objective on shares of Doximity from $19.00 to $24.00 and gave the company a "hold" rating in a report on Thursday. Finally, JPMorgan Chase & Co. increased their price objective on shares of Doximity from $26.00 to $31.00 and gave the stock a "neutral" rating in a research report on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to data from MarketBeat.com, Doximity presently has a consensus rating of "Hold" and a consensus target price of $32.10.
Read Our Latest Stock Analysis on Doximity
About Doximity
(
Get Free Report)
Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.
The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
